JOH306-20

Using Ibrutinib in Earlier Lines of Treatment Results in Better Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

imbruvica® (ibrutinib) capsule – Riassunto Delle Caratteristiche Del Prodotto

Using Ibrutinib in Earlier Lines of Treatment Results in Better Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

imbruvica® (ibrutinib) capsule – Riassunto Delle Caratteristiche Del Prodotto

Springer Healthcare